Development in Allston awaits the report of a University “work team.”

The University explores co-development in Allston that might help fund science research there, and possibly a move by the Harvard School of Public Health.

The site of the Allston science complex, where construction came to a halt in 2010.

In mid March, Harvard president Drew Faust sent a letter to Allston residents reporting that all but one of Harvard’s marketable retail properties in the community had been rented. She wrote also that an Allston “work team has been gathering information from a range of sources both inside and outside the University to help determine the best route to resumed development for the Western Avenue site, which will undoubtedly be tied to one or more science-based uses, and options for development and co-development around that anchor project.”

Because the University owns an enormous amount of land in Allston, co-development would likely take the form of ground leases to commercial developers on parcels farthest from the planned campus, perhaps near the Massachusetts Turnpike. Conceivably, Harvard could use payments on the leased land to fund a series of bonds issued to finance its share of whatever is built—at the halted University laboratory site or elsewhere nearby. There is strong demand worldwide for new biotechnology development, interest rates are at historic lows, and Allston—because of its proximity to Harvard, MIT, and Boston’s teaching hospitals—is a desirable location. 

What exactly might Harvard want to build? One scenario could involve the unmet space needs of the Harvard School of Public Health. Other institutions in the Longwood Medical Area, including Northeastern University, the Harvard teaching hospitals, Harvard Medical School, and the Wentworth Institute of Technology, all need more room there—representing opportunities should the public-health school relocate. The University has been working with development firms Leggat McCall, historically on the leasing side of the business, and McCall & Almy, focused on consulting and planning, to aid the work team, whose report on Harvard’s development strategy is due to Faust in mid summer.

You might also like

Harvard’s New Playbook for Teaching with AI

Faculty across Harvard are rethinking assignments to integrate AI. 

The Faculty of Arts and Sciences Zeroes in on the Classroom Experience

Class schedules and academics are at the top of the agenda for Harvard faculty.

Three Harvardians win MacArthur Fellowships

A mathematician, a political scientist, and an astrophysicist are honored with “genius” grants for their work.

Most popular

What Trump Means for John Roberts's Legacy

Executive power is on the docket at the Supreme Court.

Rachel Ruysch’s Lush (Still) Life

Now on display at the Museum of Fine Arts, a Dutch painter’s art proved a treasure trove for scientists.

A Flu Vaccine That Actually Works

Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.

Explore More From Current Issue

Two women in traditional Japanese clothing sitting on a wooden platform near a tranquil pond, surrounded by autumn foliage.

Japan As It Never Will Be Again

Harvard’s Stillman collection showcases glimpses of the Meiji era. 

Wolfram Schlenker wearing a suit sitting outdoors, smiling, with trees and a building in the background.

Harvard Economist Wolfram Schlenker Is Tackling Climate Change

How extreme heat affects our land—and our food supply 

Professor David Liu smiles while sitting at a desk with colorful lanterns and a figurine in the background.

This Harvard Scientist Is Changing the Future of Genetic Diseases

David Liu has pioneered breakthroughs in gene editing, creating new therapies that may lead to cures.